These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6488465)

  • 1. The bay-region geometry of some 5-methylchrysenes: steric effects in 5,6- and 5,12-dimethylchrysenes.
    Zacharias DE; Kashino S; Glusker JP; Harvey RG; Amin S; Hecht SS
    Carcinogenesis; 1984 Nov; 5(11):1421-30. PubMed ID: 6488465
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative tumor-initiating activity of methylene-bridged and bay-region methylated derivatives of benz[a]anthracene and chrysene.
    Rice JE; Jordan K; Little P; Hussain N
    Carcinogenesis; 1988 Dec; 9(12):2275-8. PubMed ID: 3191573
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bay-region distortions in a methanol adduct of a bay-region diol epoxide of the carcinogen 5-methylchrysene.
    Afshar CE; Carrell CJ; Carrell HL; Harvey RG; Kiselyov AS; Amin S; Glusker JP
    Carcinogenesis; 1996 Nov; 17(11):2507-11. PubMed ID: 8968070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 11-Methylbenzo[a]pyrene: bay region distortions.
    Prout K; Smith AD; Daub GH; Zacharias DE; Glusker JP
    Carcinogenesis; 1992 Oct; 13(10):1775-82. PubMed ID: 1423837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three-dimensional structure of anti-5,6-dimethylchrysene-1, 2-dihydrodiol-3,4-epoxide: a diol epoxide with a bay region methyl group.
    Afshar CE; Katz AK; Carrell HL; Amin S; Desai D; Glusker JP
    Carcinogenesis; 1999 Aug; 20(8):1549-53. PubMed ID: 10426805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bay region distortions in cyclopenta[a]phenanthrenes.
    Kashino S; Zacharias DE; Peck RM; Glusker JP; Bhatt TS; Coombs MM
    Cancer Res; 1986 Apr; 46(4 Pt 1):1817-29. PubMed ID: 3948165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bay- and fjord-region distortions in dibenz[a,j]anthracene and tetrabenzo[de,hi,mn,qr]naphthacene.
    Carrell CJ; Carrell HL; Glusker JP; Abu-Shaqara E; Cortez C; Harvey RG
    Carcinogenesis; 1994 Dec; 15(12):2931-6. PubMed ID: 8001258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhancing effect of a bay region methyl group on tumorigenicity in newborn mice and mouse skin of enantiomeric bay region diol epoxides formed stereoselectively from methylchrysenes in mouse epidermis.
    Hecht SS; Amin S; Huie K; Melikian AA; Harvey RG
    Cancer Res; 1987 Oct; 47(20):5310-5. PubMed ID: 3652037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and tumor-initiating activities of dimethylchrysenes.
    Amin S; Balanikas G; Huie K; Hecht SS
    Chem Res Toxicol; 1988; 1(6):349-55. PubMed ID: 2979752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shapes of carcinogenic benz[a]anthracenes: the crystal and molecular structure of 1-methylbenz[a]anthracene.
    Jones DW; Sowden JM
    Cancer Biochem Biophys; 1979; 4(1):43-7. PubMed ID: 498062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structure and molecular orbital studies of potentially mutagenic methylchrysenes and their pi-pi* electron donor-acceptor molecular complexes.
    Zacharias DE; Prout K; Myers CB; Glusker JP
    Acta Crystallogr B; 1991 Feb; 47 ( Pt 1)():97-107. PubMed ID: 2025412
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor initiating activity of 5,11-dimethylchrysene and the structural requirements favoring carcinogenicity of methylated polynuclear aromatic hydrocarbons.
    Hecht SS; Amin S; Rivenson A; Hoffmann D
    Cancer Lett; 1979 Nov; 8(1):65-70. PubMed ID: 509421
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative tumor initiating activities of cyclopentano and methyl derivatives of 5-methylchrysene and chrysene.
    Amin S; Hecht SS; Di Raddo P; Harvey RG
    Cancer Lett; 1990 May; 51(1):17-20. PubMed ID: 2337893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative tumorigenicity of dimethylchrysenes in mouse skin.
    Amin S; Desai D; Hecht SS
    Chem Res Toxicol; 1992; 5(2):237-41. PubMed ID: 1643253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Steric strain and tumorigenicity: the molecular structure of 3,6-dimethylcholanthrene.
    Jones DW; Shaw JD
    Carcinogenesis; 1989 Oct; 10(10):1829-31. PubMed ID: 2791201
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative metabolic activation in mouse skin of the weak carcinogen 6-methylchrysene and the strong carcinogen 5-methylchrysene.
    Amin S; Huie K; Melikian AA; Leszczynska JM; Hecht SS
    Cancer Res; 1985 Dec; 45(12 Pt 1):6406-42. PubMed ID: 4063989
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantum chemical studies of methyl and fluoro analogs of chrysene: metabolic activation and correlation with carcinogenic activity.
    Poulsen MT; Loew GH
    Cancer Biochem Biophys; 1981; 5(2):81-90. PubMed ID: 7248920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carcinogenicity of methylchrysenes.
    Hoffmann D; Bondinell WE; Wynder EL
    Science; 1974 Jan; 183(4121):215-6. PubMed ID: 4808861
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and mutagenicity of 5,11-dimethylchrysene and some methyl-oxidized derivatives of 5-methylchrysene.
    Amin S; Hecht SS; LaVoie E; Hoffmann D
    J Med Chem; 1979 Nov; 22(11):1336-40. PubMed ID: 392098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The molecular structure of 11-methylbenz[a]anthracene: an almost planar substituted benz[a]anthracene.
    Briant CE; Jones DW
    Carcinogenesis; 1984 Mar; 5(3):363-5. PubMed ID: 6705141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.